Conflicts of interest at the NIH

Since when is moral and ethical conduct required to be efficient and helpful?

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Since when is moral and ethical conduct required to be efficient and helpful? In a recent Opinion,1 the authors express the concept that what is proposed by NIH (after a great deal of foot dragging) is far too stringent and inefficient and not helpful. Fortunately for the public, those writers seem to be implying that those corrupt and unethical scientists are leaving in droves. I hope so. It is these morally challenged individuals who allowed questionable drugs to be brought onto the market, who touted drug therapies at medical meetings that were highly questionable, who profited at the expense of the general public.

If NIH scientists, their families, and their staffs want to invest in the health care industry they have a variety of mutual funds that can do that and avoid any semblance of conflict of interest.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Gerald Schneir

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio